309 related articles for article (PubMed ID: 30295379)
1. Update of calcineurin inhibitors to treat inverse psoriasis: A systematic review.
Dattola A; Silvestri M; Bennardo L; Del Duca E; Longo C; Bianchi L; Nisticò S
Dermatol Ther; 2018 Nov; 31(6):e12728. PubMed ID: 30295379
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of topical calcineurin inhibitors in psoriasis.
Wang C; Lin A
J Cutan Med Surg; 2014; 18(1):8-14. PubMed ID: 24377467
[TBL] [Abstract][Full Text] [Related]
3. A 5-year randomized trial on the safety and efficacy of pimecrolimus in atopic dermatitis: a critical appraisal - comment.
Charman C
Br J Dermatol; 2017 Oct; 177(4):1004-1005. PubMed ID: 28858382
[No Abstract] [Full Text] [Related]
4. Pimecrolimus for psoriasis.
Ayer J; Young HS
Expert Opin Pharmacother; 2013 Apr; 14(6):767-74. PubMed ID: 23461536
[TBL] [Abstract][Full Text] [Related]
5. Innovative use of topical calcineurin inhibitors.
Lin AN
Dermatol Clin; 2010 Jul; 28(3):535-45. PubMed ID: 20510763
[TBL] [Abstract][Full Text] [Related]
6. The use of topical tacrolimus and pimecrolimus to treat psoriasis: a review.
Scheinfeld N
Dermatol Online J; 2004 Jul; 10(1):3. PubMed ID: 15347485
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of topical calcineurin inhibitors in lichen planus.
Samycia M; Lin AN
J Cutan Med Surg; 2012; 16(4):221-9. PubMed ID: 22784514
[TBL] [Abstract][Full Text] [Related]
8. The role of topical calcineurin inhibitors in atopic dermatitis.
Alomar A; Berth-Jones J; Bos JD; Giannetti A; Reitamo S; Ruzicka T; Stalder JF; Thestrup-Pedersen K;
Br J Dermatol; 2004 Dec; 151 Suppl 70 Dec 2004():3-27. PubMed ID: 15548171
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of topical calcineurin inhibitors in vitiligo.
Wong R; Lin AN
Int J Dermatol; 2013 Apr; 52(4):491-6. PubMed ID: 23331250
[TBL] [Abstract][Full Text] [Related]
10. The role of topical calcineurin inhibitors for skin diseases other than atopic dermatitis.
Wollina U
Am J Clin Dermatol; 2007; 8(3):157-73. PubMed ID: 17492844
[TBL] [Abstract][Full Text] [Related]
11. [Calcineurin inhibitors for topical therapy in psoriasis].
Wohlrab J
Hautarzt; 2006 Aug; 57(8):685-9. PubMed ID: 16841205
[TBL] [Abstract][Full Text] [Related]
12. Use of topical corticosteroids and topical calcineurin inhibitors for the treatment of atopic dermatitis in thin and sensitive skin areas.
Draelos ZD
Curr Med Res Opin; 2008 Apr; 24(4):985-94. PubMed ID: 18284804
[TBL] [Abstract][Full Text] [Related]
13. Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: a double-blind, randomized study.
Gribetz C; Ling M; Lebwohl M; Pariser D; Draelos Z; Gottlieb AB; Zaias N; Chen DM; Parneix-Spake A; Hultsch T; Menter A
J Am Acad Dermatol; 2004 Nov; 51(5):731-8. PubMed ID: 15523351
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis.
Breuer K; Werfel T; Kapp A
Am J Clin Dermatol; 2005; 6(2):65-77. PubMed ID: 15799678
[TBL] [Abstract][Full Text] [Related]
15. How Clinically Relevant Are Treatment Comparisons of Topical Calcineurin Inhibitor Trials for Atopic Eczema?
Wilkes SR; Nankervis H; Tavernier E; Maruani A; Williams HC
J Invest Dermatol; 2016 Oct; 136(10):1944-1949. PubMed ID: 27265005
[TBL] [Abstract][Full Text] [Related]
16. Pimecrolimus 1% cream in the treatment of facial psoriasis: a 16-week open-label study.
Jacobi A; Braeutigam M; Mahler V; Schultz E; Hertl M
Dermatology; 2008; 216(2):133-6. PubMed ID: 18216475
[TBL] [Abstract][Full Text] [Related]
17. Topical Treatment of Facial Seborrheic Dermatitis: A Systematic Review.
Gupta AK; Versteeg SG
Am J Clin Dermatol; 2017 Apr; 18(2):193-213. PubMed ID: 27804089
[TBL] [Abstract][Full Text] [Related]
18. Pimecrolimus, a topical calcineurin inhibitor used in the treatment of atopic eczema.
Prucha H; Schnopp C; Akdis C; Lauener R; Wollenberg A; Ring J; Traidl-Hoffmann C
Expert Opin Drug Metab Toxicol; 2013 Nov; 9(11):1507-16. PubMed ID: 23876065
[TBL] [Abstract][Full Text] [Related]
19. Association between exposure to topical tacrolimus or pimecrolimus and cancers.
Hui RL; Lide W; Chan J; Schottinger J; Yoshinaga M; Millares M
Ann Pharmacother; 2009 Dec; 43(12):1956-63. PubMed ID: 19903860
[TBL] [Abstract][Full Text] [Related]
20. Pimecrolimus: a review of its use in atopic dermatitis.
Wellington K; Noble S
Am J Clin Dermatol; 2004; 5(6):479-95. PubMed ID: 15663345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
